Langerhans cell histiocytosis of the head and neck in the pediatric population in a tertiary center: Clinical presentation, classification and treatment
- PMID: 35220158
- DOI: 10.1016/j.ijporl.2022.111073
Langerhans cell histiocytosis of the head and neck in the pediatric population in a tertiary center: Clinical presentation, classification and treatment
Abstract
Introduction: Langerhans cell histiocytosis (LCH) is a rare disease of unknown etiology with a heterogeneous and unspecific clinical presentation. Any organ or system may be involved but the most frequent is the skeleton. The diagnostic gold standard is done through histopathology combined with immunohistochemistry in the correct clinical setting. Treatment is still controversial. The objective of this study is to present a series of pediatric patients in order to contribute to the diagnosis and treatment of LCH.
Material and methods: A longitudinal, descriptive and retrospective study was done in 20 pediatric patients histologically diagnosed of LCH int the last 10 years, in a tertiary center. A review of the medical history was done and data collection included: epidemiological data, clinical manifestations and classification, lesion characteristics, treatment employed, follow-up and evolution.
Results: The mean age presentation was 6.5 years (2-12). The most frequent disease presentation was a palpable skull tumor followed by headache. Other otorhinolaryngologic presenting symptoms were bloody otorrhea and post auricular swelling. Single-systems LCH with skull tumors was the most frequent classification. Treatment options (surgery, chemotherapy and corticosteroid infiltration) were indicated according to disease classification.
Conclusion: LCH should be suspected in pediatric patients with a palpable cranial vault tumor, as well as in patients with chronic otorrhea with granulation tissue at the external ear canal. Management of LCH fundamentally includes chemotherapy and surgery, or the combination of both. High-risk organs lesions, including temporal bone lesions, and multi-system LCH are predictors of recurrence and should have a long-term follow-up.
Keywords: Birbeck granules; Head and neck; Langerhans cell histiocytosis; Langerin; Pediatric; Temporal bone.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.Laryngoscope. 2016 Aug;126(8):1899-904. doi: 10.1002/lary.25773. Epub 2015 Nov 4. Laryngoscope. 2016. PMID: 26535795
-
Langerhans' cell histiocytosis of the temporal bone in children.Int J Pediatr Otorhinolaryngol. 2008 Jun;72(6):775-86. doi: 10.1016/j.ijporl.2008.02.001. Epub 2008 Mar 19. Int J Pediatr Otorhinolaryngol. 2008. PMID: 18355926
-
Pediatric Langerhans cell histiocytosis of the lateral skull base.Int J Pediatr Otorhinolaryngol. 2017 Aug;99:135-140. doi: 10.1016/j.ijporl.2017.06.011. Epub 2017 Jun 15. Int J Pediatr Otorhinolaryngol. 2017. PMID: 28688556
-
Craniofacial involvement in Langerhans cell histiocytosis: A review of 44 cases at a single medical center.J Plast Reconstr Aesthet Surg. 2023 Jul;82:12-20. doi: 10.1016/j.bjps.2023.03.006. Epub 2023 Mar 21. J Plast Reconstr Aesthet Surg. 2023. PMID: 37148805 Review.
-
Oral manifestations of Langerhans cell histiocytosis with unusual histomorphologic features.Ann Diagn Pathol. 2020 Aug;47:151536. doi: 10.1016/j.anndiagpath.2020.151536. Epub 2020 May 21. Ann Diagn Pathol. 2020. PMID: 32454442 Review.
Cited by
-
Oral mucosal lesions with transient self-healing of Langerhans cell histiocytosis: a case report.Hua Xi Kou Qiang Yi Xue Za Zhi. 2023 Oct 1;41(5):592-598. doi: 10.7518/hxkq.2023.2023084. Hua Xi Kou Qiang Yi Xue Za Zhi. 2023. PMID: 37805684 Free PMC article. Chinese, English.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources